Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4745697
Max Phase: Preclinical
Molecular Formula: C28H32NO10P
Molecular Weight: 573.54
Molecule Type: Unknown
Associated Items:
ID: ALA4745697
Max Phase: Preclinical
Molecular Formula: C28H32NO10P
Molecular Weight: 573.54
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCc1ccccc1OCc1cccc(Oc2ccccc2)c1
Standard InChI: InChI=1S/C28H32NO10P/c1-20(17-36-40(33,34)37-19-25(29)28(31)32)38-27(30)15-14-22-9-5-6-13-26(22)35-18-21-8-7-12-24(16-21)39-23-10-3-2-4-11-23/h2-13,16,20,25H,14-15,17-19,29H2,1H3,(H,31,32)(H,33,34)/t20-,25+/m1/s1
Standard InChI Key: WTQTXPXOHUNDIF-NLFFAJNJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 573.54 | Molecular Weight (Monoisotopic): 573.1764 | AlogP: 4.47 | #Rotatable Bonds: 16 |
Polar Surface Area: 163.84 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.57 | CX Basic pKa: 9.38 | CX LogP: 2.58 | CX LogD: -0.49 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.16 | Np Likeness Score: 0.01 |
1. Nakamura S,Sayama M,Uwamizu A,Jung S,Ikubo M,Otani Y,Kano K,Omi J,Inoue A,Aoki J,Ohwada T. (2020) Non-naturally Occurring Regio Isomer of Lysophosphatidylserine Exhibits Potent Agonistic Activity toward G Protein-Coupled Receptors., 63 (17): [PMID:32787112] [10.1021/acs.jmedchem.0c01126] |
Source(1):